Metal Ions as Activators of Hypoxia Inducible Factor
- Authors: Osipyants A.I.1, Smirnova N.A.1, Khristichenko A.Y.1, Nikulin S.V.1, Zakhariants A.A.2, Tishkov V.I.3,2, Gazaryan I.G.1,3, Poloznikov A.A.1
-
Affiliations:
- Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
- Innovations and High Technologies MSU Ltd.
- Faculty of Chemistry
- Issue: Vol 73, No 1 (2018)
- Pages: 13-18
- Section: Article
- URL: https://journal-vniispk.ru/0027-1314/article/view/163588
- DOI: https://doi.org/10.3103/S0027131418020128
- ID: 163588
Cite item
Abstract
Activation of antihypoxic program under the action of a number of transition and heavy metals has been studied using cell-based HIF1 ODD-luc and HRE-luc reporters. It has been demonstrated that Au3+, Pb2+, Sn2+, Hg2+ are weak HIF1 ODD-luc activators, likely reflecting their weak competition for the ironbinding site in the active center of HIF prolyl hydroxylase. Metals capable of replacing iron–Mn2+, Zn2+, Cu2+ и Ni2+–activate at high submillimolar concentrations, which indicates low permeability of the cell membrane for transition metals. The highest activation is observed for Co2+ and Cd2+, however, Cd2+ is highly toxic even at 10 μM, in contrast to Co2+, which activates both reporters without toxicity signs up to 25 μM for 24 h. A significant activation by Co2+ is observed already in low micromolar range of concentrations, which can be recommended for use in hypoxia mimicking.
Keywords
About the authors
A. I. Osipyants
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Author for correspondence.
Email: osssip@gmail.com
Russian Federation, Moscow, 117997
N. A. Smirnova
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Email: osssip@gmail.com
Russian Federation, Moscow, 117997
A. Yu. Khristichenko
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Email: osssip@gmail.com
Russian Federation, Moscow, 117997
S. V. Nikulin
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Email: osssip@gmail.com
Russian Federation, Moscow, 117997
A. A. Zakhariants
Innovations and High Technologies MSU Ltd.
Email: osssip@gmail.com
Russian Federation, Moscow, 109451
V. I. Tishkov
Faculty of Chemistry; Innovations and High Technologies MSU Ltd.
Email: osssip@gmail.com
Russian Federation, Moscow, 119991; Moscow, 109451
I. G. Gazaryan
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia; Faculty of Chemistry
Email: osssip@gmail.com
Russian Federation, Moscow, 117997; Moscow, 119991
A. A. Poloznikov
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Email: osssip@gmail.com
Russian Federation, Moscow, 117997
Supplementary files
